Abametapir

Abametapir is a drug used to treat head lice. It is an oral medication that works by killing the lice and preventing them from reproducing. It is available in both over-the-counter and prescription forms. The over-the-counter form of Abametapir is called Ulesfia and is approved by the Food and Drug Administration (FDA) for the treatment of head lice. The prescription form of Abametapir is called Ovide and is used to treat body lice. Abametapir works by paralyzing and killing the lice, and then preventing them from reproducing. It is generally well-tolerated and safe for use in adults and children age 6 months and older.

Abametapir is a medication sold under the brand name Xeglyze. It is used for the treatment of head lice infestation in people six months of age and older. Abametapir belongs to a new class of medications called metalloproteinase inhibitors. It works by killing lice and their eggs.

Here's a summary of some key points about Abametapir:

  • Uses: Treats head lice infestation in people aged 6 months and older.
  • Mechanism of action: Acts as a metalloproteinase inhibitor, killing lice and their eggs.
  • Dosage: Single topical application to the hair and scalp.
  • Common side effects: Skin redness, rash, burning sensation, inflammation, vomiting, eye irritation, itching, and hair color changes.
  • Advantages: Single application treatment, effective against lice eggs.

Important to note:

  • Abametapir may interact with certain other medications. Be sure to tell your doctor about all the medications you are taking before using Abametapir.
  • Abametapir is not a cure for head lice. It is important to follow all of your doctor's instructions carefully to get rid of lice completely.
Anatomical Therapeutic Chemical Classification
P - Antiparasitic products, insecticides and repellents
P03 Ectoparasiticides, including scabicides, insecticides and repellents
P03A - Ectoparasiticides, including scabicides
P03AX Other ectoparasiticides, including scabicides
External Links